Essex Investment Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-47,169
| Closed | -$507K | – | 441 |
|
|
2022
Q3 | $507K | Sell |
47,169
-3,236
| -6% | -$34.8K | 0.08% | 240 |
|
|
2022
Q2 | $604K | Buy |
50,405
+18,365
| +57% | +$220K | 0.1% | 239 |
|
|
2022
Q1 | $686K | Buy |
32,040
+777
| +2% | +$16.6K | 0.09% | 249 |
|
|
2021
Q4 | $1.05M | Buy |
31,263
+6,471
| +26% | +$218K | 0.12% | 223 |
|
|
2021
Q3 | $638K | Buy |
+24,792
| New | +$638K | 0.08% | 251 |
|
|
2019
Q2 | – | Sell |
-22,987
| Closed | -$302K | – | 523 |
|
|
2019
Q1 | $302K | Sell |
22,987
-26,950
| -54% | -$354K | 0.04% | 306 |
|
|
2018
Q4 | $722K | Buy |
+49,937
| New | +$722K | 0.11% | 231 |
|